ORPEA : Good timing to anticipate a continuation of the trend
Entry price | Target | Stop-loss | Potential |
---|
€99.56 |
€110 |
€94.9 |
+10.49% |
---|
The current trading zone is interesting to the point that investors should pay attention to the stock and anticipate a return of the underlying upward trend.
Strengths● Predictions on business development from analysts polled by Thomson-Reuters are tight. This results from either a good visibility into core activities or accurate earnings releases.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The stock is in a well-established, long-term rising trend above the technical support level at 85.39 EUR
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 103.1.
● The stock is close to a major daily resistance at EUR 103.6, which should be gotten rid of so as to gain new appreciation potential.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The firm trades with high earnings multiples: 29.21 times its 2017 earnings per share.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.